This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gao, Q. Articles by Band, V. Search for Related Content PubMed PubMed Citation Articles by Gao, Q. Articles by Band, V.

Human Papillomavirus E6-induced Degradation of E6TP1 Is Mediated by E6AP Ubiquitin Ligase¹

Division of Radiation and Cancer Biology, Department of Radiation Oncology, New England Medical Center [Q. G., A. K., L. S., S. S., D. E. W., V. B.], and Department of Biochemistry, Tufts University School of Medicine [V. B.], Boston, Massachusetts 02111; Institute for Cellular and Molecular Biology, Section of Molecular Genetics and Microbiology, University of Texas at Austin, Austin, Texas 78712-1095 [J. M. H., S. B.]; and Laboratory of Lymphocyte Biology, Division of Rheumatology, Immunology and Allergy, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02111 [H. B.]

High-risk human papilloma viruses are known to be associated with cervical cancers. We have reported previously that the high-risk human papillomavirus (HPV) E6 oncoprotein interacts with E6TP1, a novel Rap GTPase-activating protein (RapGAP). Similar to p53 tumor suppressor protein, the high-risk HPV E6 oncoproteins target E6TP1 for degradation. The HPV16 E6-induced degradation of E6TP1 strongly correlates with its ability to immortalize human mammary epithelial cells. In this study, we used treatment with a proteasome inhibitor MG132, analysis in CHO-ts20 cells with a thermolabile ubiquitin-activating enzyme, and direct detection of ubiquitin-modified E6TP1 to demonstrate that E6TP1 is targeted for degradation by the ubiquitin-proteasome pathway both in the presence and in the absence of E6. Using deletion mutants of E6TP1, we mapped the region required and sufficient for E6 binding to COOH-terminal 40 amino acid residues and showed this region to be necessary for E6-dependent degradation of E6TP1. Furthermore, the E6-binding region of E6TP1 complexes with E6AP via E6. Importantly, the purified E6AP enhanced the ubiquitination and degradation of E6TP1 in the presence of E6 in vitro. Additionally, the expression of a dominant-negative E6AP mutant (C833A) in cells inhibited the E6-induced degradation of E6TP1. These findings demonstrate that the E6-induced decrease in the levels of E6TP1 protein involves the E6AP-mediated ubiquitination followed by proteasome-dependent degradation.

This article has been cited by other articles:

				A. Nellore, K. Paziana, C. Ma, O. M. Tsygankova, Y. Wang, K. Puttaswamy, A. U. Iqbal, S. R. Franks, Y. Lv, A. B. Troxel, et al. Loss of Rap1GAP in Papillary Thyroid Cancer J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 1026 - 1032. [Abstract] [Full Text] [PDF]

				H. Zheng, L. Gao, Y. Feng, L. Yuan, H. Zhao, and L. A. Cornelius Down-regulation of Rap1GAP via Promoter Hypermethylation Promotes Melanoma Cell Proliferation, Survival, and Migration Cancer Res., January 15, 2009; 69(2): 449 - 457. [Abstract] [Full Text] [PDF]

				L. Zheng, H. Ding, Z. Lu, Y. Li, Y. Pan, T. Ning, and Y. Ke E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Genes Cells, March 1, 2008; 13(3): 285 - 294. [Abstract] [Full Text] [PDF]

				O. M. Tsygankova, G. V. Prendergast, K. Puttaswamy, Y. Wang, M. D. Feldman, H. Wang, M. S. Brose, and J. L. Meinkoth Downregulation of Rap1GAP Contributes to Ras Transformation Mol. Cell. Biol., October 1, 2007; 27(19): 6647 - 6658. [Abstract] [Full Text] [PDF]

				K. Kometani, M. Aoki, S. Kawamata, Y. Shinozuka, T. Era, M. Taniwaki, M. Hattori, and N. Minato Role of SPA-1 in Phenotypes of Chronic Myelogenous Leukemia Induced by BCR-ABL-Expressing Hematopoietic Progenitors in a Mouse Model. Cancer Res., October 15, 2006; 66(20): 9967 - 9976. [Abstract] [Full Text] [PDF]

				A. Mani, A. S. Oh, E. T. Bowden, T. Lahusen, K. L. Lorick, A. M. Weissman, R. Schlegel, A. Wellstein, and A. T. Riegel E6AP Mediates Regulated Proteasomal Degradation of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 in Immortalized Cells. Cancer Res., September 1, 2006; 66(17): 8680 - 8686. [Abstract] [Full Text] [PDF]

				A. Hengstermann, M. A. D'silva, P. Kuballa, K. Butz, F. Hoppe-Seyler, and M. Scheffner Growth Suppression Induced by Downregulation of E6-AP Expression in Human Papillomavirus-Positive Cancer Cell Lines Depends on p53 J. Virol., July 15, 2005; 79(14): 9296 - 9300. [Abstract] [Full Text] [PDF]

				A. Favre-Bonvin, C. Reynaud, C. Kretz-Remy, and P. Jalinot Human Papillomavirus Type 18 E6 Protein Binds the Cellular PDZ Protein TIP-2/GIPC, Which Is Involved in Transforming Growth Factor {beta} Signaling and Triggers Its Degradation by the Proteasome J. Virol., April 1, 2005; 79(7): 4229 - 4237. [Abstract] [Full Text] [PDF]

				X. Liu, H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse, and R. Schlegel The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein J. Biol. Chem., March 18, 2005; 280(11): 10807 - 10816. [Abstract] [Full Text] [PDF]

				M. L. Kelley, K. E. Keiger, C. J. Lee, and J. M. Huibregtse The Global Transcriptional Effects of the Human Papillomavirus E6 Protein in Cervical Carcinoma Cell Lines Are Mediated by the E6AP Ubiquitin Ligase J. Virol., March 15, 2005; 79(6): 3737 - 3747. [Abstract] [Full Text] [PDF]

				M. Hattori and N. Minato Rap1 GTPase: Functions, Regulation, and Malignancy J. Biochem., October 1, 2003; 134(4): 479 - 484. [Abstract] [Full Text] [PDF]

				L. Su, M. Hattori, M. Moriyama, N. Murata, M. Harazaki, K. Kaibuchi, and N. Minato AF-6 Controls Integrin-mediated Cell Adhesion by Regulating Rap1 Activation through the Specific Recruitment of Rap1GTP and SPA-1 J. Biol. Chem., April 18, 2003; 278(17): 15232 - 15238. [Abstract] [Full Text] [PDF]

				L. Singh, Q. Gao, A. Kumar, T. Gotoh, D. E. Wazer, H. Band, L. A. Feig, and V. Band The High-Risk Human Papillomavirus Type 16 E6 Counters the GAP Function of E6TP1 toward Small Rap G Proteins J. Virol., December 20, 2002; 77(2): 1614 - 1620. [Abstract] [Full Text] [PDF]